High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Emory University
Emory University
Merck Sharp & Dohme LLC
Exelixis
National Cancer Institute (NCI)
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Genmab
MedSIR
Sotio Biotech Inc.
Rondo Therapeutics
Bayer
The Netherlands Cancer Institute
Bristol-Myers Squibb
Merck Sharp & Dohme LLC
QuantumLeap Healthcare Collaborative
PMV Pharmaceuticals, Inc
Mayo Clinic
Dartmouth-Hitchcock Medical Center
NeoImmuneTech
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Dana-Farber Cancer Institute
Seagen Inc.
Japanese Foundation for Cancer Research
Merck Sharp & Dohme LLC
Tizona Therapeutics, Inc
Memorial Sloan Kettering Cancer Center
Emory University
Washington University School of Medicine
Roswell Park Cancer Institute
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Institute of Cancer Research, United Kingdom
Wake Forest University Health Sciences
City of Hope Medical Center
Emory University
M.D. Anderson Cancer Center
The Methodist Hospital Research Institute
Gilead Sciences
Providence Health & Services
Eli Lilly and Company
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Seagen Inc.
Novartis
PharmAbcine
University of Chicago
University of Illinois at Chicago